Should Surgery Be Performed for Sarcomatoid Mesothelioma?

• Maja Belamaric
• Mesothelioma, Treatments
• June 3, 2026

Sarcomatoid mesothelioma is widely recognized as the most aggressive and rare form of mesothelioma. Because of how quickly it spreads and how poorly it responds to treatment, surgery is often not considered a helpful option for most patients.

Still, recent research suggests that there may be limited situations where surgery could play a role. The decision is complex and depends heavily on the patient’s overall health, disease stage, and treatment plan.

Difficulty Treating Sarcomatoid Mesothelioma

Mesothelioma develops in the lining of the lungs and is most often linked to asbestos exposure. It is generally divided into three main types: epithelioid, biphasic, and sarcomatoid.

Among these, sarcomatoid mesothelioma is the least common and the most aggressive. It tends to spread quickly through the chest and surrounding tissues and is often resistant to standard treatments like chemotherapy and radiation.

Because of this behavior, patients with sarcomatoid mesothelioma typically have a shorter life expectancy than those with other cell types. In many cases, survival is measured in months rather than years.

Why is Surgery Not Recommended for Treatment of Sarcomatoid Mesothelioma

Surgery for mesothelioma is designed to remove as much visible tumor as possible. However, sarcomatoid mesothelioma often grows in a diffuse pattern, making complete removal extremely difficult.

Research has shown that surgical treatment does not consistently improve survival for patients with sarcomatoid disease. In fact, outcomes for surgery in this subtype are generally poor compared to other forms of mesothelioma.

For this reason, many clinical guidelines advise against surgery for sarcomatoid mesothelioma, especially when the disease is advanced or has spread widely.

What Recent Research Suggests

Although surgery is not typically recommended, newer studies have explored whether carefully selected patients might benefit from an aggressive, multi-step treatment approach.

One recent clinical study by Dr. Raphael Bueno and his team at Brigham and Women’s Hospital examined outcomes of patients with sarcomatoid mesothelioma who underwent a lung-sparing surgical procedure known as pleurectomy / decortication, where the lining of the lung and visible tumor are removed while the lung itself is preserved.

The study found that:

• Surgery is not standard, but may feasible in selected cases, on carefully selected individuals and only at specialized centers.
• Multimodal therapy is key and other modalities of treatment must be used. The study was conducted prior to the approval of immunotherapy for mesothelioma, so it doesn’t take into account benefits achieved through systemic immunotherapy treatments which could further help improve outcomes in sarcomatoid mesothelioma.

The Role of Multimodal Treatment

Today, doctors are more likely to consider a combination approach rather than surgery alone. This is often referred to as multimodal therapy.

Multimodal treatment may include:

• Surgery in select cases
• Chemotherapy before or after surgery
• Emerging treatments such as immunotherapy
• Supportive care to manage symptoms and maintain quality of life

Even in cases where surgery is considered, it is rarely used on its own. It is typically part of a broader treatment strategy aimed at controlling the disease rather than curing it.

Selection Criteria for Patients with the Sarcomatoid Subtype of Mesothelioma

One of the most important factors in determining whether surgery might be appropriate is patient selection.

Patients with better lung function and overall physical health tend to tolerate aggressive treatments more effectively. In some studies, individuals with strong pre-surgical lung capacity showed longer survival compared to those with weaker respiratory function.

Other factors doctors evaluate include:

• Stage of the disease
• Extent of tumor spread
• Overall health and age
• Ability to tolerate additional therapies

Even with these considerations, surgery remains controversial for sarcomatoid mesothelioma.

The Bottom Line

For most patients with sarcomatoid mesothelioma, surgery is not a standard or highly effective treatment option. The disease is usually too aggressive, and outcomes after surgery alone are generally limited.

However, in rare and carefully selected cases, surgery may be considered as part of a broader treatment plan that includes chemotherapy or other therapies.

Because every case is different, treatment decisions should always be made by a specialized mesothelioma care team with experience in managing this rare cancer type.

To discuss treatment options for your specific situation, including a potential surgical resection, contact our expert mesothelioma nurse.